Knight Therapeutics | GUD - Capital Ordinaire

Prix De L'Action
6.82
Variation Quotidienne
0.41 6.40%
Mensuellement
6.90%
Annuel
14.24%
Q1 Prévisions
6.25




Capital Ordinaire Changement Date
Acasti Pharma USD 1000 261.04M 2024-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.21M 131K 2025-09
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Canopy Growth CAD 368.28M 35.9M 2025-12
Cronos Group USD 382.89M 286.14M 2025-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Moderna USD 391M 2M 2025-09
Omeros USD 611K 17K 2023-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Organon & Co USD 259.98M 18K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 6.55M 2025-09
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12